Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BillionToOne

BillionToOne
2016 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Seed LATEST DEAL TYPE
$2.5M LATEST DEAL AMOUNT
15 INVESTORS
Description

Developer of a molecular blood test to take advantage of the freely circulating fetal DNA in the maternal bloodstream designed to determine whether the fetus has any genetic disorders. The company's prenatal testing procedure focuses on quantitative biology and statistical learning methods to optimize signal-to-noise ratio, thereby making it possible to detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy and cystic fibrosis through a simple blood test.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Devices and Supplies
Primary Office
  • 1455 Adams Drive
  • Suite 1110
  • Menlo Park, CA 94025
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BillionToOne’s full profile, request a free trial.

BillionToOne Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 30-Sep-2017 $2.5M 000.00 Completed Clinical Trials - General
2. Early Stage VC (Series A) 13-Mar-2019 0000 0000 0000 Completed Clinical Trials - General
1. Accelerator/Incubator 22-Aug-2017 Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

BillionToOne Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A-6 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-5 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-4 00,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-3 000,000 00.000000 00 00 00 00 0.000
Series A-2 1,137,210 $0.000010 $0.8 $0.8 1x $0.8 5.83%
Series A-1 1,349,650 $0.000010 $0.4 $0.4 1x $0.4 6.92%
To view this company’s complete Cap Table, request access »

BillionToOne Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Good Start Genetics Formerly VC-backed Cambridge, MA 000 000.00 000000&0 000.00
0000000 Formerly VC-backed San Francisco, CA 0000 00000 00000000000 00000
0000000000 0000000 Corporate Backed or Acquired Cambridge, MA 000 00000 00000000000
000000 Formerly VC-backed San Carlos, CA 000 00000 000000 - 000 00000
00000000 000000 Formerly VC-backed Redwood City, CA 000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

BillionToOne Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
HOF Capital Growth/Expansion Minority 000 0000 000000 0
Hummingbird Ventures Venture Capital Minority 000 0000 000000 0
Neotribe Ventures Venture Capital Minority 000 0000 000000 0
500 Startups Accelerator/Incubator Minority 000 0000 000000 0
Civilization Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

BillionToOne Executive Team (3)

Name Title Board
Seat
Contact
Info
Oguzhan Atay Ph.D Co-Founder, Chief Executive Officer & Chairman
David Tsao Ph.D Co-Founder, Chief Technology Officer & Board Member

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »

BillionToOne Board Members (5)

Name Representing Role Since Contact
Info
David Tsao Ph.D BillionToOne Co-Founder, Chief Technology Officer & Board Member 000 0000
Firat Ileri Hummingbird Ventures Board Member 000 0000
Krishna Swaroop Kolluri Neotribe Ventures Board Member 000 0000
Oguzhan Atay Ph.D BillionToOne Co-Founder, Chief Executive Officer & Chairman 000 0000

1 Former Board Member

You’re viewing 4 of 5 board members. Get the full list »